Autoimmune lymphoproliferative syndrome natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:
===Complications===
===Complications===
*Common [[complication]] of [[Autoimmune lymphoproliferative syndrome]] include:
*Common [[complication]] of [[Autoimmune lymphoproliferative syndrome]] include:
**[[Lymphoma]] both Hodgkins and non Hodgkins
**[[Lymphoma]] both [[Hodgkins]] and [[Non Hodgkins lymphoma]].<ref name="ShahWu2014">{{cite journal|last1=Shah|first1=Shaili|last2=Wu|first2=Eveline|last3=Rao|first3=V. Koneti|last4=Tarrant|first4=Teresa K.|title=Autoimmune Lymphoproliferative Syndrome: an Update and Review of the Literature|journal=Current Allergy and Asthma Reports|volume=14|issue=9|year=2014|issn=1529-7322|doi=10.1007/s11882-014-0462-4}}</ref>
**[[Sepsis]] follwed by [[splenectomy]]


===Prognosis===
===Prognosis===

Revision as of 05:15, 26 June 2021

Autoimmune lymphoproliferative syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune lymphoproliferative syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autoimmune lymphoproliferative syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune lymphoproliferative syndrome natural history, complications and prognosis

CDC on Autoimmune lymphoproliferative syndrome natural history, complications and prognosis

Autoimmune lymphoproliferative syndrome natural history, complications and prognosis in the news

Blogs on Autoimmune lymphoproliferative syndrome natural history, complications and prognosis

Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome

Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
  • Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

  1. Bride, Karen; Teachey, David (2017). "Autoimmune lymphoproliferative syndrome: more than a FAScinating disease". F1000Research. 6: 1928. doi:10.12688/f1000research.11545.1. ISSN 2046-1402.
  2. 2.0 2.1 Shah, Shaili; Wu, Eveline; Rao, V. Koneti; Tarrant, Teresa K. (2014). "Autoimmune Lymphoproliferative Syndrome: an Update and Review of the Literature". Current Allergy and Asthma Reports. 14 (9). doi:10.1007/s11882-014-0462-4. ISSN 1529-7322.

Template:WH Template:WS